BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 8, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 1, 2015
View Archived Issues
PROTACs: tagging disease-associated proteins for degradation
Read More
C9orf72 knockout insufficient to cause motor neuron diseases in mice
Read More
PeptiDream and Teijin agree discovery collaboration
Read More
Bone Therapeutics initiates trial of ALLOB for minimally invasive revision spinal surgery
Read More
Intrexon and Ziopharm Oncology form exclusive channel collaboration in GvHD
Read More
PPOX identified as a new target for colorectal cancer therapy
Read More
Aldeyra Therapeutics enrolls first patient in phase IIa trial of NS-2
Read More
Novan Therapeutics reports IIb trial data for SB-204 for in acne vulgaris
Read More
Macrophage Therapeutics produces first two immunoconstructs
Read More
BLU-554 receives FDA orphan drug designation for hepatocellular carcinoma
Read More
Polyphor/Roche macrocyclic peptide to combat multidrug-resistant bacterial infections
Read More
PTC Therapeutics submits variation for new indication in Europe for Translarna
Read More
BiondVax begins phase IIb trial of universal flu vaccine in Europe
Read More
SEQ-9, a novel macrolide for the treatment of tuberculosis
Read More
Zosano discontinues daily ZP-PTH and resumes development of weekly formulation
Read More
Novel 2-pyridone antibacterials to treat Gram-negative bacterial infections
Read More
AMO Pharma raises funds to advance clinical-stage candidates and expand pipeline
Read More
reMYND develops new compounds for protein-misfolding disorders
Read More
iTeos Therapeutics describes TDO2 inhibitors
Read More
Tyme submits phase II IND application for SM-88
Read More
Incretin effect identified as a predictor of prediabetes in women with previous GDM
Read More
Trillium advances TTI-621 towards phase I trials
Read More
Merck & Co. presents SYK inhibitors
Read More
FDA awards QIDP designation to Ixogel for prevention of Lyme disease
Read More
Ignyta initiates phase II trial of entrectinib
Read More
BioMarin to acquire global rights to Kuvan and pegvaliase from Merck Serono
Read More